Month: August 2006

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

Existing therapies for major depression have a lag of onset of action of several weeks, resulting in considerable morbidity. Exploring pharmacological strategies that have rapid onset of antidepressant effects within a few days and that are sustained would have an enormous impact on patient care. Converging lines of evidence suggest the role of the glutamatergic...

MORE

Popular Blog Posts

“What will my ketamine infusion feel like?”

Ketamine therapy for OCD

At our Boulder Mind Care (in Boulder) and Transcendent Ketamine of Colorado (in Fort Collins), we provide dramatic relief…

LEARN MORE

The Denver Post features Transcendent Ketamine of Colorado & Boulder Mind Care December 24 2023

We were honored to be recently featured recently in The Denver Post, at https://www.denverpost.com/2022/12/24/ketamine-infusions-depression-chronic-pain-colorado. It is always beneficial when…

LEARN MORE

The Pandemic, Teen Depression, and Suicide Risk

Measures to contain the spread of coronavirus have inadvertently increased teen depression and suicide risk, as demonstrated by Mayne…

LEARN MORE

Ketamine Infusion Therapy for PTSD – Results of an Important New Study

A recent study[1] published in the January 5, 2021 American Journal of Psychiatry by Dr. Adriana Feder and her…

LEARN MORE

Ketamine – The Most Powerful Treatment For Depression Yet Invented

Ketamine continues to gain recognition, by both lay public and medical professionals, as a remarkably effective antidepressant, with minimal…

LEARN MORE